PT2515886T - Sistema terapêutico transdermal para a administração de rivastigmina ou de seus derivados - Google Patents
Sistema terapêutico transdermal para a administração de rivastigmina ou de seus derivadosInfo
- Publication number
- PT2515886T PT2515886T PT107905655T PT10790565T PT2515886T PT 2515886 T PT2515886 T PT 2515886T PT 107905655 T PT107905655 T PT 107905655T PT 10790565 T PT10790565 T PT 10790565T PT 2515886 T PT2515886 T PT 2515886T
- Authority
- PT
- Portugal
- Prior art keywords
- derivatives
- therapeutic system
- transdermal therapeutic
- administering rivastigmine
- rivastigmine
- Prior art date
Links
- XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 title 1
- 229960004136 rivastigmine Drugs 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
- A61F13/00991—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacturing & Machinery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09180413 | 2009-12-22 | ||
| EP10154648 | 2010-02-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2515886T true PT2515886T (pt) | 2018-05-23 |
Family
ID=43383419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT107905655T PT2515886T (pt) | 2009-12-22 | 2010-12-14 | Sistema terapêutico transdermal para a administração de rivastigmina ou de seus derivados |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8962014B2 (OSRAM) |
| EP (1) | EP2515886B1 (OSRAM) |
| JP (1) | JP6083734B2 (OSRAM) |
| KR (1) | KR101674240B1 (OSRAM) |
| CN (1) | CN102711744B (OSRAM) |
| AU (1) | AU2010335309B2 (OSRAM) |
| BR (1) | BR112012017168B1 (OSRAM) |
| CA (1) | CA2785117C (OSRAM) |
| CY (1) | CY1120283T1 (OSRAM) |
| DK (1) | DK2515886T3 (OSRAM) |
| ES (1) | ES2670227T3 (OSRAM) |
| MX (1) | MX350357B (OSRAM) |
| NO (1) | NO2515886T3 (OSRAM) |
| PL (1) | PL2515886T3 (OSRAM) |
| PT (1) | PT2515886T (OSRAM) |
| WO (1) | WO2011076621A2 (OSRAM) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2641821T3 (es) | 2009-10-30 | 2017-11-14 | Ix Biopharma Ltd | Forma de dosificación sólida de disolución rápida |
| US12186426B2 (en) | 2009-10-30 | 2025-01-07 | Ix Biopharma Ltd. | Solid dosage form |
| DE102010026903A1 (de) | 2010-07-12 | 2012-01-12 | Amw Gmbh | Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff |
| DK2468274T3 (en) * | 2010-12-14 | 2015-08-31 | Acino Ag | Transdermal therapeutic system for administration of an active substance |
| JP6017543B2 (ja) * | 2011-05-20 | 2016-11-02 | エスケー ケミカルズ カンパニー, リミテッドSk Chemicals Co., Ltd. | リバスティグミン含有パッチ |
| WO2013006643A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
| JP6102739B2 (ja) * | 2011-08-31 | 2017-03-29 | 東洋インキＳｃホールディングス株式会社 | 貼付剤 |
| EP2594261A1 (en) | 2011-11-18 | 2013-05-22 | Labtec GmbH | Composition for transdermal administration of rivastigmine |
| DE102012000369A1 (de) | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
| WO2013128562A1 (ja) | 2012-02-28 | 2013-09-06 | ニチバン株式会社 | 貼付剤 |
| US20140083878A1 (en) * | 2012-09-21 | 2014-03-27 | Mylan Inc. | Transdermal drug delivery device |
| CN103933018A (zh) * | 2013-01-18 | 2014-07-23 | 江苏康倍得药业有限公司 | 一种透皮给药系统 |
| JPWO2015174502A1 (ja) | 2014-05-15 | 2017-05-25 | ニチバン株式会社 | リバスチグミンを含有する貼付剤のための包装体 |
| RU2667448C1 (ru) | 2014-09-23 | 2018-09-19 | Эквистар Кемикалз, Лп | Составы на основе полиолефина, клейкие вещества и получаемые многослойные структуры |
| JP2018511355A (ja) | 2015-01-28 | 2018-04-26 | クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | 薬剤送達方法及びシステム |
| AU2016228779A1 (en) | 2015-03-12 | 2017-09-07 | Chrono Therapeutics Inc. | Craving input and support system |
| DE102015119789A1 (de) * | 2015-11-16 | 2017-05-18 | Denso-Holding Gmbh & Co. | Korrosionsschutzzusammensetzung umfassend Polyisobutylene |
| JP2020503950A (ja) | 2017-01-06 | 2020-02-06 | クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | 経皮薬剤送達の装置及び方法 |
| WO2018175825A1 (en) | 2017-03-24 | 2018-09-27 | E Ink California, Llc | Microcell systems for delivering active molecules |
| TWI670089B (zh) | 2017-03-24 | 2019-09-01 | 美商伊英克加利福尼亞有限責任公司 | 用於調節活性物投送速率之包含帶電或磁性粒子的微胞遞送系統 |
| EP3709972B1 (en) | 2017-11-14 | 2022-03-30 | E Ink California, LLC | Electrophoretic active delivery system including porous conductive electrode layer |
| CN112040936B (zh) * | 2018-04-17 | 2024-07-23 | 罗曼治疗系统股份公司 | 用于透皮施用索利那新的透皮治疗系统 |
| EP3801732A4 (en) | 2018-05-29 | 2022-04-27 | Morningside Venture Investments Limited | Drug delivery methods and systems |
| WO2020102695A1 (en) | 2018-11-16 | 2020-05-22 | Cti (Assignment For Benefit Of Creditors) Llc | Thermally regulated transdermal drug delivery system |
| US11938214B2 (en) | 2019-11-27 | 2024-03-26 | E Ink Corporation | Benefit agent delivery system comprising microcells having an electrically eroding sealing layer |
| EP4236927A4 (en) | 2020-10-29 | 2024-10-16 | E Ink Corporation | MICROCELL SYSTEMS FOR DELIVERY OF HYDROPHILIC ACTIVE MOLECULES |
| EP4236926A4 (en) | 2020-10-29 | 2024-08-28 | E Ink Corporation | MICROCELL SYSTEMS FOR DELIVERY OF BENEFICIAL AGENTS |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL195004C (nl) | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
| JPS63307818A (ja) | 1987-06-08 | 1988-12-15 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
| JPH07116025B2 (ja) | 1988-03-11 | 1995-12-13 | 積水化学工業株式会社 | 貼付剤 |
| JP2693212B2 (ja) * | 1989-03-28 | 1997-12-24 | 日東電工株式会社 | 疾患治療用テープ製剤 |
| JPH08193030A (ja) * | 1995-01-12 | 1996-07-30 | Nitto Denko Corp | エメダスチン貼付製剤 |
| JPH10152434A (ja) * | 1996-09-26 | 1998-06-09 | Nitto Denko Corp | 経皮吸収型製剤 |
| GB9800526D0 (en) | 1998-01-12 | 1998-03-11 | Ciba Geigy Ag | Organic compounds |
| DE19814087A1 (de) * | 1998-03-30 | 1999-10-14 | Lohmann Therapie Syst Lts | Feuchtigkeitsaktivierbares therapeutisches System |
| DE19918106A1 (de) | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
| DE10033853A1 (de) | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| DE10141652B4 (de) | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
| WO2003032960A1 (en) * | 2001-10-17 | 2003-04-24 | Hisamitsu Pharmaceutical Co., Inc. | Percutaneous absorption preparations |
| JP4478757B2 (ja) | 2002-04-19 | 2010-06-09 | 日東電工株式会社 | ビソプロロール含有貼付剤 |
| BRPI0518396A2 (pt) * | 2004-12-27 | 2008-11-18 | Eisai R&D Man Co Ltd | mÉtodo para estabilizaÇço de droga anti-demÊncia |
| TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
| CN1994290B (zh) * | 2006-01-04 | 2011-03-16 | 上海医药工业研究院 | 卡巴拉汀透皮贴剂及其制备方法 |
| BRPI0621655A2 (pt) * | 2006-05-08 | 2011-12-20 | Teikoku Seiyaku Kk | preparação para a absorção percutánea de uma droga antidemência básica |
| US9248104B2 (en) | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
| JP2009022730A (ja) * | 2007-06-18 | 2009-02-05 | Kyoritsu Yakuhin Kogyo Kk | 貼付剤 |
-
2010
- 2010-12-14 NO NO10790565A patent/NO2515886T3/no unknown
- 2010-12-14 DK DK10790565.5T patent/DK2515886T3/en active
- 2010-12-14 AU AU2010335309A patent/AU2010335309B2/en active Active
- 2010-12-14 KR KR1020127017374A patent/KR101674240B1/ko active Active
- 2010-12-14 EP EP10790565.5A patent/EP2515886B1/de active Active
- 2010-12-14 PL PL10790565T patent/PL2515886T3/pl unknown
- 2010-12-14 WO PCT/EP2010/069654 patent/WO2011076621A2/de not_active Ceased
- 2010-12-14 MX MX2012007214A patent/MX350357B/es active IP Right Grant
- 2010-12-14 CN CN201080059296.4A patent/CN102711744B/zh active Active
- 2010-12-14 CA CA2785117A patent/CA2785117C/en active Active
- 2010-12-14 BR BR112012017168-2A patent/BR112012017168B1/pt active IP Right Grant
- 2010-12-14 PT PT107905655T patent/PT2515886T/pt unknown
- 2010-12-14 JP JP2012545226A patent/JP6083734B2/ja active Active
- 2010-12-14 US US13/518,006 patent/US8962014B2/en active Active
- 2010-12-14 ES ES10790565.5T patent/ES2670227T3/es active Active
-
2018
- 2018-05-25 CY CY20181100570T patent/CY1120283T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL2515886T3 (pl) | 2018-08-31 |
| MX2012007214A (es) | 2012-09-12 |
| MX350357B (es) | 2017-09-05 |
| AU2010335309B2 (en) | 2015-08-20 |
| AU2010335309A1 (en) | 2012-07-19 |
| US20130261571A1 (en) | 2013-10-03 |
| US8962014B2 (en) | 2015-02-24 |
| CN102711744A (zh) | 2012-10-03 |
| CA2785117C (en) | 2016-12-06 |
| BR112012017168B1 (pt) | 2022-03-15 |
| KR101674240B1 (ko) | 2016-11-08 |
| WO2011076621A3 (de) | 2012-02-09 |
| CN102711744B (zh) | 2014-06-25 |
| EP2515886B1 (de) | 2018-04-11 |
| JP2013515025A (ja) | 2013-05-02 |
| EP2515886A2 (de) | 2012-10-31 |
| DK2515886T3 (en) | 2018-06-14 |
| ES2670227T3 (es) | 2018-05-29 |
| JP6083734B2 (ja) | 2017-02-22 |
| NO2515886T3 (OSRAM) | 2018-09-08 |
| BR112012017168A2 (pt) | 2018-05-02 |
| KR20120128606A (ko) | 2012-11-27 |
| WO2011076621A2 (de) | 2011-06-30 |
| CA2785117A1 (en) | 2011-06-30 |
| CY1120283T1 (el) | 2019-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2515886T (pt) | Sistema terapêutico transdermal para a administração de rivastigmina ou de seus derivados | |
| PL2560624T3 (pl) | Formulacja terapeutyczna do zmniejszania skutków ubocznych leku | |
| EP2299989A4 (en) | STERILIZED TRANSDERMAL DRUG DELIVERY SYSTEM | |
| EP2240236A4 (en) | SKIN THERAPY SYSTEM | |
| IL219073A (en) | A drug combination for cancer treatment | |
| IL221007A (en) | Pharmaceutical combinations for antiviral therapy | |
| EP2392307A4 (en) | DEVICE FOR CONTROLLING DOSAGE OF DRUG SOLUTION | |
| IL214402A0 (en) | Transdermal pharmaceutical preparations | |
| PL2379132T3 (pl) | Układ i sposób infuzji leku | |
| ZA201303965B (en) | Transdermal therapeutic system for administering an active substance | |
| SI2464342T1 (sl) | Farmacevtske formulacije proti zlorabi zdravil | |
| ZA201005663B (en) | Transdermal therapeutic system having stabilized membrane | |
| EP2424611A4 (en) | DEVICE FOR TRANSDERMAL ADMINISTRATIONS | |
| AP3250A (en) | Tablets for combination therapy | |
| PL2616133T3 (pl) | Aparaty do podawania leków przez skórę | |
| ZA201208646B (en) | Pharmaceutical combination for the treatment of pain | |
| PT3005986T (pt) | Infusão de drogas | |
| ZA201403497B (en) | Transdermal therapeutic system for administering fentanyl or analogue thereof | |
| GB0906159D0 (en) | Drug combination for the treatment of proteostatic diseases | |
| ZA201301458B (en) | Therapeutic agent for pain | |
| ZA200809004B (en) | Autodestructive transdermal therapeutic system | |
| EP2601954A4 (en) | THERAPEUTIC FOR DISEASES | |
| PL385972A1 (pl) | Kompozycja farmaceutyczna do leczenia chorób przyzębia | |
| EP2485719A4 (en) | TRANSDERMAL THERAPEUTIC SYSTEM | |
| ZA201201894B (en) | Pharmaceutical combination for treating tumor |